StockNews.com Lowers Heron Therapeutics (NASDAQ:HRTX) to Sel

StockNews.com lowered shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) from a hold rating to a sell rating in a report published on Wednesday morning. Several other brokerages also recently weighed in on HRTX. Cantor Fitzgerald reissued an overweight rating on shares of Heron Therapeutics in a report on Monday, July 10th. Needham & Company […]

Related Keywords

San Diego , California , United States , America , Adam Morgan , Millennium Management , Jw Asset Management , Jefferies Financial Group Inc , Heron Therapeutics Inc , Needham Company , Heron Therapeutics Company Profile , Cantor Fitzgerald , America Corp , Heron Therapeutics , Free Report , Get Free Report , Director Adam Morgan , Street Corp , Financial Group , Heron Therapeutics Daily , Nasdaq Hrtx , Hrtx , Medical , Downgrade , Stocknews Com ,